<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7479EFF8-8EF7-479B-BB26-3D844EB92D8E"><gtr:id>7479EFF8-8EF7-479B-BB26-3D844EB92D8E</gtr:id><gtr:name>University of Goettingen</gtr:name><gtr:address><gtr:line1>Windausweg 2</gtr:line1><gtr:postCode>D-37073</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6F5F667B-3844-49DF-948F-FCA983560AF9"><gtr:id>6F5F667B-3844-49DF-948F-FCA983560AF9</gtr:id><gtr:name>Hannover Medical School</gtr:name><gtr:address><gtr:line1>Carl-Neuberg-Str. 1</gtr:line1><gtr:postCode>D-30625</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A179E2C-FB5E-4836-AA80-6301F4DD5AB6"><gtr:id>4A179E2C-FB5E-4836-AA80-6301F4DD5AB6</gtr:id><gtr:name>University of Sydney</gtr:name><gtr:address><gtr:line1>University of Sydney</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Immunity and Infection</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7479EFF8-8EF7-479B-BB26-3D844EB92D8E"><gtr:id>7479EFF8-8EF7-479B-BB26-3D844EB92D8E</gtr:id><gtr:name>University of Goettingen</gtr:name><gtr:address><gtr:line1>Windausweg 2</gtr:line1><gtr:postCode>D-37073</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6F5F667B-3844-49DF-948F-FCA983560AF9"><gtr:id>6F5F667B-3844-49DF-948F-FCA983560AF9</gtr:id><gtr:name>Hannover Medical School</gtr:name><gtr:address><gtr:line1>Carl-Neuberg-Str. 1</gtr:line1><gtr:postCode>D-30625</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A179E2C-FB5E-4836-AA80-6301F4DD5AB6"><gtr:id>4A179E2C-FB5E-4836-AA80-6301F4DD5AB6</gtr:id><gtr:name>University of Sydney</gtr:name><gtr:address><gtr:line1>University of Sydney</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F584CF83-EA22-44B9-B4DA-2BB970774AAD"><gtr:id>F584CF83-EA22-44B9-B4DA-2BB970774AAD</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>R</gtr:otherNames><gtr:surname>Clark</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800207"><gtr:id>0D9143C1-2182-44D8-9D3A-ACF7A20F41EA</gtr:id><gtr:title>Control of inflammation via the phosphorylation of tristetraprolin (TTP)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800207</gtr:grantReference><gtr:abstractText>Inflammation is normally a short-lived and beneficial response to infection or injury. However, in diseases like rheumatoid arthritis, inflammation persists in the absence of infection or injury, causing pain, disfunction and disfigurement. It is possible that persistent inflammation is due to the failure of resolution mechanisms, which would normally help to terminate an inflammatory response. In this project we are exploring the idea of stimulating or reactivating one of the body s natural inflammatory off-switches in order to treat chronic inflammatory diseases.</gtr:abstractText><gtr:technicalSummary>This project will investigate the impact of signalling pathways on the expression and function of the mRNA destabilising protein tristetraprolin (TTP), a negative regulator of inflammatory mediator gene expression. We will investigate the hypothesis that TTP is present at sites of chronic inflammation but inactivated by phosphorylation. We will examine the feasibility of reactivating latent TTP as a novel anti-inflammatory strategy.</gtr:technicalSummary><gtr:fund><gtr:end>2013-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-01-05</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>569065</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of G?ttingen</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Medical School</gtr:department><gtr:description>Role of TTP in neuronal inflammation</gtr:description><gtr:id>C952676D-A64F-4EC4-AC81-4D038CCBA94E</gtr:id><gtr:impact>Some preliminary findings, manuscript to follow soon.</gtr:impact><gtr:outcomeId>546276cdad7319.30989383-1</gtr:outcomeId><gtr:partnerContribution>Prof Trendelenburg's group performed aortic exclusion experiments to test whether TTPala mice were protected from ischaemia-induced neuronal damage.</gtr:partnerContribution><gtr:piContribution>I provided the TTPala mouse to Prof George Trendelenburg for investigation of a possible protective role of TTP in an experimental model of stroke.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Newcastle</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Role of TTP in respiratory inflammation</gtr:description><gtr:id>229BFE6A-BC3C-423D-B6C3-E004C1C3D70F</gtr:id><gtr:impact>Two manuscripts have been submitted for publication by my Australian collaborators, others are in preparation.</gtr:impact><gtr:outcomeId>54627537ddc221.19413459-2</gtr:outcomeId><gtr:partnerContribution>My collaborators are expert in several experimental models of pulmonary inflammation, and are able to assess in vivo consequences of the targeted mutation of the gene encoding TTP in those models. These methods are not accessible to me at the University of Birmingham.</gtr:partnerContribution><gtr:piContribution>I provided the TTPala mouse to my collaborators in Australia, as part of a project funded by NHMRC, entitled &amp;quot;Novel strategies to boost Tristetraprolin function: a critical anti-inflammatory protein in asthma&amp;quot;. I continue to provide advice on experimental design and interpretation.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sydney</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Role of TTP in respiratory inflammation</gtr:description><gtr:id>2E5F333F-5AA4-4E10-A4E9-94DAE6824A06</gtr:id><gtr:impact>Two manuscripts have been submitted for publication by my Australian collaborators, others are in preparation.</gtr:impact><gtr:outcomeId>54627537ddc221.19413459-1</gtr:outcomeId><gtr:partnerContribution>My collaborators are expert in several experimental models of pulmonary inflammation, and are able to assess in vivo consequences of the targeted mutation of the gene encoding TTP in those models. These methods are not accessible to me at the University of Birmingham.</gtr:partnerContribution><gtr:piContribution>I provided the TTPala mouse to my collaborators in Australia, as part of a project funded by NHMRC, entitled &amp;quot;Novel strategies to boost Tristetraprolin function: a critical anti-inflammatory protein in asthma&amp;quot;. I continue to provide advice on experimental design and interpretation.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hannover Medical School</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Cooperation of MK2 and TTP</gtr:description><gtr:id>C2CD4713-8994-4D64-B4A7-5201DECF493C</gtr:id><gtr:impact>Non yet. Breeding still in progress.</gtr:impact><gtr:outcomeId>56d57bbe04afa7.97075069-1</gtr:outcomeId><gtr:partnerContribution>Partners contributed Mk2-/- mice, and are carrying out a cross with the Zfp36aa/aa strain. The intention is to determine how phosphorylation of TTP contributes to regulation of inflammation by MK2, and whether kinases other than MK2 target serines 52 and 178 of TTP.</gtr:partnerContribution><gtr:piContribution>We contributed genetically modified Zfp36aa/aa mice for breeding.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Cross between Dusp1 knockout mouse strain and the TTPala strain, which expresses a non-phosphorylatable form of TTP.</gtr:description><gtr:id>2943A259-EFB4-473E-B50A-B501036EBBF9</gtr:id><gtr:impact>This allows us to delineate an important mechanism of action of glucocorticoids in the regulation of inflammatory responses.</gtr:impact><gtr:outcomeId>oRs5mquAJMv</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Dusp1 - TTPala cross</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Stable macrophage cell line expressing epitope tagged TTP</gtr:description><gtr:id>0FE3028A-FDF8-4917-B6E4-0E6FD796C405</gtr:id><gtr:impact>Allows us to purify large quantities of TTP and use mass spectrometric methods to identify interacting partners and sites of post-translational modification.</gtr:impact><gtr:outcomeId>8AC87C9A8DC</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>RAW264.7-FlagTTP</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Agilent array-based analysis of responses to dexamethasone in BMMs of mouse strains wt, Dusp1-/-, Zfp36aa/aa, Dusp1-/- : Zfp36aa/aa</gtr:description><gtr:id>0D96E03B-D5CD-4252-A1EA-3C00784CE4B6</gtr:id><gtr:impact>The data have (in part) been made publicly available through the Gene Expression Omnibus
This forms the basis of new insights into anti-inflammatory actions of glucocorticoids</gtr:impact><gtr:outcomeId>B3GvsqNMkCg</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>GC response microarray</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE68449</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We generated a knock-in mouse in which two phospho-acceptor sites of TTP were mutated to non-phosphorylatable alanine residues</gtr:description><gtr:id>06A30C16-801A-44EE-9266-2C0573E1F9F2</gtr:id><gtr:impact>We demonstrated that the knock-in mouse is remarkably resistant to pro-inflammatory challenges, in spite of the fact tha the mRNA destabilising protein TTP is expressed at extremely low levels.</gtr:impact><gtr:outcomeId>UFoCzXybTpE</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>TTP-Ala mouse</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We developed antibodies against TTP phosphorylated at Ser52 and Ser178.</gtr:description><gtr:id>9034CCBD-84CE-42D8-9AD6-839ECAD9688E</gtr:id><gtr:impact>These allow us to track phosphorylation and activation state of TTP in mammalian cells. We hope to apply them to clinical samples also.</gtr:impact><gtr:outcomeId>7CBA0D83DC4</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Anti phospho-TTP antibodies</gtr:title><gtr:type>Antibody</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We used mass spectrometry to identify a large number of proteins that specifically interact with TTP.</gtr:description><gtr:id>B196803B-D2BA-4B88-BBA0-E38DE4692FF2</gtr:id><gtr:impact>Identified components of a deadenylase complex which mediates the mRNA degrading action of TTP.</gtr:impact><gtr:outcomeId>gHkEckibG2Y</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>TTP interactome</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Mass spectrometry was used to identify sites of phosphorylation of Flag-TTP in macrophages stimulated with LPS.</gtr:description><gtr:id>9673FA08-F7EF-43A7-9522-74BBBEE934A4</gtr:id><gtr:impact>This step is critical for understanding how LPS-activated signalling pathways modulate the expression and activity of TTP.</gtr:impact><gtr:outcomeId>71C7A94AC4A</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Sites of LPS-induced TTP phosphorylation</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Targeting construct for generation of mouse knock-in lacking TTP phosphorylation sites.</gtr:description><gtr:id>1263A0DA-01F0-4CA4-9211-0D09203FD768</gtr:id><gtr:impact>The construct was successfully used for targeted mutation of two serine residues in the murine Zfp36 locus to alanine residues.</gtr:impact><gtr:outcomeId>09E172C1D9E</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>CLA1-HR</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Microarray-based analysis of changes of LPS-induced gene expression in mouse macrophages expressing a mutant (constitutively active) form of TTP</gtr:description><gtr:id>875CC03F-51A7-4A2B-AE90-12AE13FA9A5C</gtr:id><gtr:impact>These data are described in two papers published back-to-back in the Journal of Inflammation in 2015. The entire data set has been depositied in the Gene Expression Omnibus archive, with accession numbr GSE68449.</gtr:impact><gtr:outcomeId>YiiZsXMELZs</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>TTPaa microarray</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE68449</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>8594FCB3-BFA1-4C3E-B51E-7D955AC65CD8</gtr:id><gtr:title>Targeting PP2A and proteasome activity ameliorates features of allergic airway disease in mice.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79db79166b33f67251fa807885702559"><gtr:id>79db79166b33f67251fa807885702559</gtr:id><gtr:otherNames>Nair PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>5aaa3b738a69c9.46606917</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5913F7E4-4048-4C4D-9AD8-3178121AAEE7</gtr:id><gtr:title>Tryptophan-Mediated Interactions between Tristetraprolin and the CNOT9 Subunit Are Required for CCR4-NOT Deadenylase Complex Recruitment.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0c5d8b2501faf127c7bb710b1927f92"><gtr:id>b0c5d8b2501faf127c7bb710b1927f92</gtr:id><gtr:otherNames>Bulbrook D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>5aaa3b73200dc5.21134498</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB25859A-9BE9-498F-8B9E-758506B18013</gtr:id><gtr:title>The control of inflammation via the phosphorylation and dephosphorylation of tristetraprolin: a tale of two phosphatases.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84cd706fd428fd5617882f223cc4fd53"><gtr:id>84cd706fd428fd5617882f223cc4fd53</gtr:id><gtr:otherNames>Clark AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>583d971e5f9814.15516352</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6FD0FFB-DED1-4F66-80C4-E6C286C08CE6</gtr:id><gtr:title>Basal protein phosphatase 2A activity restrains cytokine expression: role for MAPKs and tristetraprolin.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83f3ccdd3d9c40609709789abafc51c4"><gtr:id>83f3ccdd3d9c40609709789abafc51c4</gtr:id><gtr:otherNames>Rahman MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>565c14ba18cb21.56779334</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A97CCB35-7D98-4369-AE30-D11EDAB73948</gtr:id><gtr:title>Temporal regulation of cytokine mRNA expression by tristetraprolin: dynamic control by p38 MAPK and MKP-1.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Lung cellular and molecular physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/091c81e23913038c9d102f0a5344fa71"><gtr:id>091c81e23913038c9d102f0a5344fa71</gtr:id><gtr:otherNames>Prabhala P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1040-0605</gtr:issn><gtr:outcomeId>565c14ba416149.86887155</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F29F58B-F6E9-468E-8DF5-A618890CE94E</gtr:id><gtr:title>Beta Interferon Production Is Regulated by p38 Mitogen-Activated Protein Kinase in Macrophages via both MSK1/2- and Tristetraprolin-Dependent Pathways.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a421ad3f54cb2085f40ce1aa163aada7"><gtr:id>a421ad3f54cb2085f40ce1aa163aada7</gtr:id><gtr:otherNames>McGuire VA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>583d96190f84b0.99843194</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBB00A5E-01FB-40DB-9A61-EA50116A801C</gtr:id><gtr:title>Gain-of-Function Mutation of Tristetraprolin Impairs Negative Feedback Control of Macrophagesyet Has Overwhelmingly Anti-Inflammatory Consequences.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a6020025387fdca1890bb565fd3f69f"><gtr:id>0a6020025387fdca1890bb565fd3f69f</gtr:id><gtr:otherNames>O'Neil JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>58c905dcaf0396.12553204</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E10C1BFA-4180-4425-806B-71B975D5DF07</gtr:id><gtr:title>MAPK p38 regulates inflammatory gene expression via tristetraprolin: Doing good by stealth.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a6020025387fdca1890bb565fd3f69f"><gtr:id>0a6020025387fdca1890bb565fd3f69f</gtr:id><gtr:otherNames>O'Neil JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>5a21aeafc678e4.58002054</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99033945-A197-429A-8CE8-2E14808C08B0</gtr:id><gtr:title>Macrophage responses to lipopolysaccharide are modulated by a feedback loop involving prostaglandin E, dual specificity phosphatase 1 and tristetraprolin.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ab368e946473871205b39fa67de072f"><gtr:id>9ab368e946473871205b39fa67de072f</gtr:id><gtr:otherNames>Tang T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a21aeb015da15.41395212</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09E5A721-C884-4BA7-82F7-89566826BFFC</gtr:id><gtr:title>Dual-Specificity Phosphatase 1 and Tristetraprolin Cooperate To Regulate Macrophage Responses to Lipopolysaccharide.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/745c202dafdb006637ca20a32d6798a5"><gtr:id>745c202dafdb006637ca20a32d6798a5</gtr:id><gtr:otherNames>Smallie T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>565c14b9a849d8.16246882</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA34893E-03E9-4DD5-A2C5-2549F20722E5</gtr:id><gtr:title>Dominant Suppression of Inflammation via Targeted Mutation of the mRNA Destabilizing Protein Tristetraprolin.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8815e62a6f3fd63500acb52e99dbbeb"><gtr:id>a8815e62a6f3fd63500acb52e99dbbeb</gtr:id><gtr:otherNames>Ross EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>565c14b9e12377.19518347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABDF308C-0479-49B0-AB02-124CF5AFBBC8</gtr:id><gtr:title>The RNA-binding protein Tristetraprolin (TTP) is a critical negative regulator of the NLRP3 inflammasome.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cc71c9cbe816adc0a856ff2495e369a"><gtr:id>5cc71c9cbe816adc0a856ff2495e369a</gtr:id><gtr:otherNames>Haneklaus M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5a21aeb04a45b3.08944411</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0ABD6D83-2C67-4531-A64A-C8BE69113B7F</gtr:id><gtr:title>Treatment of inflammatory arthritis via targeting of tristetraprolin, a master regulator of pro-inflammatory gene expression.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8815e62a6f3fd63500acb52e99dbbeb"><gtr:id>a8815e62a6f3fd63500acb52e99dbbeb</gtr:id><gtr:otherNames>Ross EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>5836d8e3b6e980.60274908</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800207</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>